Recall of Cannabis for Medical Purposes - Aurora Cannabis Enterprises Inc.
- Starting date:
- November 16, 2017
- Posting date:
- November 16, 2017
- Type of communication:
- Drug Recall
- Hazard classification:
- Type II
- Source of recall:
- Health Canada
- Labelling and Packaging
- General Public
- Identification number:
On November 16, 2017, Aurora Cannabis Enterprises Inc., a licensed producer of cannabis for medical purposes located in Alberta, began a voluntary recall of one lot of Sundance borealis blend (sativa) dried marijuana under a Type II recall. The affected lot number can be found below.
On November 16, 2017, Aurora Cannabis Enterprises Inc. initiated a voluntary Type II recall for one lot of Sundance borealis blend (sativa), sold in 5 g bottles, due to an error in packaging of the product. The delta-9-tetrahydrocannabinol (THC) content identified on the label was higher and the cannabidiol (CBD) content identified on the label was lower than the concentration present in the product.
- For lot 17-118-2042, the products packaged contained a THC value of 16.2% instead of 8.17% THC, and a CBD value of 0.05% instead of 5.91% CBD.
A Type II recall refers to a situation in which the use of, or exposure to a product may cause temporary adverse health consequences, or where the probability of serious adverse health consequences is remote.
To date, Health Canada has not received any adverse reaction reports for this product sold by Aurora Cannabis Enterprises Inc. However, Health Canada recommends that any individual affected by the recall immediately stop using the recalled product and to contact Aurora Cannabis Enterprises Inc. at the following number 1-604-331-3434.
Sundance borealis blend (sativa)
DIN, NPN, DIN-HIM
8.17% THC, 5.91% CBD
Lot or serial number
The following lot is classified under the Type II recall initiated on November 16, 2017.
- Recalling Firm
Aurora Cannabis Enterprises Inc.
- Marketing Authorization Holder